CN113546049A - Flexible pill medicine adhesive and flexible pill prepared by using same - Google Patents
Flexible pill medicine adhesive and flexible pill prepared by using same Download PDFInfo
- Publication number
- CN113546049A CN113546049A CN202110485920.7A CN202110485920A CN113546049A CN 113546049 A CN113546049 A CN 113546049A CN 202110485920 A CN202110485920 A CN 202110485920A CN 113546049 A CN113546049 A CN 113546049A
- Authority
- CN
- China
- Prior art keywords
- pill
- adhesive
- test
- present
- prepared
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000006187 pill Substances 0.000 title claims abstract description 158
- 239000000853 adhesive Substances 0.000 title claims abstract description 92
- 230000001070 adhesive effect Effects 0.000 title claims abstract description 92
- 239000003814 drug Substances 0.000 title claims abstract description 33
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 183
- 239000001768 carboxy methyl cellulose Substances 0.000 claims abstract description 63
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims abstract description 32
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims abstract description 32
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims abstract description 32
- 239000000203 mixture Substances 0.000 claims abstract description 27
- 150000003839 salts Chemical class 0.000 claims abstract description 17
- 239000000843 powder Substances 0.000 claims description 80
- 235000011187 glycerol Nutrition 0.000 claims description 66
- 239000008188 pellet Substances 0.000 claims description 37
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims description 31
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims description 31
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 claims description 31
- 238000010438 heat treatment Methods 0.000 claims description 29
- 238000002360 preparation method Methods 0.000 claims description 29
- 238000002156 mixing Methods 0.000 claims description 28
- 238000003756 stirring Methods 0.000 claims description 23
- 239000011230 binding agent Substances 0.000 claims description 15
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 14
- 239000011575 calcium Substances 0.000 claims description 14
- 229910052791 calcium Inorganic materials 0.000 claims description 14
- 238000007789 sealing Methods 0.000 claims description 11
- 229940079593 drug Drugs 0.000 claims description 10
- 239000000284 extract Substances 0.000 claims description 10
- 238000009472 formulation Methods 0.000 claims description 7
- 239000000463 material Substances 0.000 abstract description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 18
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 abstract description 8
- 239000011248 coating agent Substances 0.000 abstract description 8
- 238000000576 coating method Methods 0.000 abstract description 8
- 238000003860 storage Methods 0.000 abstract description 6
- 230000009286 beneficial effect Effects 0.000 abstract description 5
- 238000001035 drying Methods 0.000 abstract description 4
- 229910052742 iron Inorganic materials 0.000 abstract description 4
- 239000000126 substance Substances 0.000 abstract description 4
- 231100000252 nontoxic Toxicity 0.000 abstract description 3
- 230000003000 nontoxic effect Effects 0.000 abstract description 3
- 238000004904 shortening Methods 0.000 abstract description 3
- 238000012360 testing method Methods 0.000 description 134
- 230000008961 swelling Effects 0.000 description 49
- 239000011734 sodium Substances 0.000 description 27
- 229940105329 carboxymethylcellulose Drugs 0.000 description 23
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 18
- 241000405414 Rehmannia Species 0.000 description 13
- 108010010803 Gelatin Proteins 0.000 description 12
- 229940084030 carboxymethylcellulose calcium Drugs 0.000 description 12
- 238000002474 experimental method Methods 0.000 description 12
- 229920000159 gelatin Polymers 0.000 description 12
- 239000008273 gelatin Substances 0.000 description 12
- 235000019322 gelatine Nutrition 0.000 description 12
- 235000011852 gelatine desserts Nutrition 0.000 description 12
- 241000209020 Cornus Species 0.000 description 9
- 238000000034 method Methods 0.000 description 9
- 238000010586 diagram Methods 0.000 description 8
- 239000002671 adjuvant Substances 0.000 description 7
- 235000012907 honey Nutrition 0.000 description 7
- 229940068918 polyethylene glycol 400 Drugs 0.000 description 7
- 238000007873 sieving Methods 0.000 description 7
- 229940049638 carbomer homopolymer type c Drugs 0.000 description 6
- 229940043234 carbomer-940 Drugs 0.000 description 6
- 235000019382 gum benzoic Nutrition 0.000 description 6
- 239000000546 pharmaceutical excipient Substances 0.000 description 6
- 238000010298 pulverizing process Methods 0.000 description 6
- 230000003716 rejuvenation Effects 0.000 description 6
- 239000002904 solvent Substances 0.000 description 6
- 238000005303 weighing Methods 0.000 description 6
- 244000215068 Acacia senegal Species 0.000 description 5
- 235000002722 Dioscorea batatas Nutrition 0.000 description 5
- 235000006536 Dioscorea esculenta Nutrition 0.000 description 5
- 240000001811 Dioscorea oppositifolia Species 0.000 description 5
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 description 5
- 229920000084 Gum arabic Polymers 0.000 description 5
- 235000008599 Poria cocos Nutrition 0.000 description 5
- 244000197580 Poria cocos Species 0.000 description 5
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 5
- 244000303379 Styrax officinalis Species 0.000 description 5
- 235000001361 Styrax officinalis Nutrition 0.000 description 5
- 239000000205 acacia gum Substances 0.000 description 5
- 235000010489 acacia gum Nutrition 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- 238000005453 pelletization Methods 0.000 description 4
- 238000012216 screening Methods 0.000 description 4
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 3
- 241000049624 Alisma plantago-aquatica subsp. orientale Species 0.000 description 3
- 235000004415 Burchellia bubalina Nutrition 0.000 description 3
- 240000008537 Burchellia bubalina Species 0.000 description 3
- 235000003889 Paeonia suffruticosa Nutrition 0.000 description 3
- 240000005001 Paeonia suffruticosa Species 0.000 description 3
- 235000001188 Peltandra virginica Nutrition 0.000 description 3
- 235000013399 edible fruits Nutrition 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 235000013772 propylene glycol Nutrition 0.000 description 3
- 229960004063 propylene glycol Drugs 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 description 2
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 2
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 2
- JHGWQSGWUPCKNT-UHFFFAOYSA-N 2-tert-butyl-4-methyl-1,3,5-trinitrobenzene Chemical compound CC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C(C(C)(C)C)=C1[N+]([O-])=O JHGWQSGWUPCKNT-UHFFFAOYSA-N 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- 241000132012 Atractylodes Species 0.000 description 2
- 235000007516 Chrysanthemum Nutrition 0.000 description 2
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 2
- 240000002624 Mespilus germanica Species 0.000 description 2
- 235000017784 Mespilus germanica Nutrition 0.000 description 2
- 235000000560 Mimusops elengi Nutrition 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- 235000007837 Vangueria infausta Nutrition 0.000 description 2
- ISAOCJYIOMOJEB-UHFFFAOYSA-N benzoin Chemical compound C=1C=CC=CC=1C(O)C(=O)C1=CC=CC=C1 ISAOCJYIOMOJEB-UHFFFAOYSA-N 0.000 description 2
- 229940116229 borneol Drugs 0.000 description 2
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 description 2
- 229960001631 carbomer Drugs 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 229910052956 cinnabar Inorganic materials 0.000 description 2
- 238000005336 cracking Methods 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 description 2
- 235000013312 flour Nutrition 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 238000000227 grinding Methods 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 2
- 229920000053 polysorbate 80 Polymers 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- URAYPUMNDPQOKB-UHFFFAOYSA-N triacetin Chemical compound CC(=O)OCC(OC(C)=O)COC(C)=O URAYPUMNDPQOKB-UHFFFAOYSA-N 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- 240000000031 Achyranthes bidentata Species 0.000 description 1
- 241000382455 Angelica sinensis Species 0.000 description 1
- 240000005528 Arctium lappa Species 0.000 description 1
- 235000003130 Arctium lappa Nutrition 0.000 description 1
- 235000008078 Arctium minus Nutrition 0.000 description 1
- 241000045403 Astragalus propinquus Species 0.000 description 1
- 235000003717 Boswellia sacra Nutrition 0.000 description 1
- 235000012035 Boswellia serrata Nutrition 0.000 description 1
- 240000007551 Boswellia serrata Species 0.000 description 1
- 241000282817 Bovidae Species 0.000 description 1
- 235000010149 Brassica rapa subsp chinensis Nutrition 0.000 description 1
- 235000000536 Brassica rapa subsp pekinensis Nutrition 0.000 description 1
- 241000499436 Brassica rapa subsp. pekinensis Species 0.000 description 1
- 235000008671 Calycanthus floridus Nutrition 0.000 description 1
- 244000025311 Calycanthus occidentalis Species 0.000 description 1
- 235000008670 Calycanthus occidentalis Nutrition 0.000 description 1
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 description 1
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 description 1
- 241000005787 Cistanche Species 0.000 description 1
- 241000903946 Clematidis Species 0.000 description 1
- 241000007126 Codonopsis pilosula Species 0.000 description 1
- 241000037740 Coptis chinensis Species 0.000 description 1
- 241000218176 Corydalis Species 0.000 description 1
- 241000123589 Dipsacus Species 0.000 description 1
- 235000015489 Emblica officinalis Nutrition 0.000 description 1
- 240000006927 Foeniculum vulgare Species 0.000 description 1
- 235000004204 Foeniculum vulgare Nutrition 0.000 description 1
- 239000004863 Frankincense Substances 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 244000153234 Hibiscus abelmoschus Species 0.000 description 1
- 235000002598 Inula helenium Nutrition 0.000 description 1
- 244000116484 Inula helenium Species 0.000 description 1
- 240000007890 Leonurus cardiaca Species 0.000 description 1
- 235000000802 Leonurus cardiaca ssp. villosus Nutrition 0.000 description 1
- 241000244355 Ligusticum Species 0.000 description 1
- 241000112528 Ligusticum striatum Species 0.000 description 1
- 241000830535 Ligustrum lucidum Species 0.000 description 1
- 235000004520 Lindera benzoin Nutrition 0.000 description 1
- 235000008262 Lindera benzoin var. benzoin Nutrition 0.000 description 1
- 235000019510 Long pepper Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 241001106477 Paeoniaceae Species 0.000 description 1
- 235000003143 Panax notoginseng Nutrition 0.000 description 1
- 241000180649 Panax notoginseng Species 0.000 description 1
- 240000003455 Piper longum Species 0.000 description 1
- 244000274050 Platycodon grandiflorum Species 0.000 description 1
- 235000006753 Platycodon grandiflorum Nutrition 0.000 description 1
- 235000010575 Pueraria lobata Nutrition 0.000 description 1
- 244000046146 Pueraria lobata Species 0.000 description 1
- 240000007651 Rubus glaucus Species 0.000 description 1
- 235000011034 Rubus glaucus Nutrition 0.000 description 1
- 235000009122 Rubus idaeus Nutrition 0.000 description 1
- 241000304195 Salvia miltiorrhiza Species 0.000 description 1
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 description 1
- 235000008282 Sanguisorba officinalis Nutrition 0.000 description 1
- 244000173853 Sanguisorba officinalis Species 0.000 description 1
- 240000000513 Santalum album Species 0.000 description 1
- 235000008632 Santalum album Nutrition 0.000 description 1
- 241000951473 Schizonepeta Species 0.000 description 1
- 235000017089 Scutellaria baicalensis Nutrition 0.000 description 1
- 240000004534 Scutellaria baicalensis Species 0.000 description 1
- 244000028419 Styrax benzoin Species 0.000 description 1
- 235000000126 Styrax benzoin Nutrition 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 235000008411 Sumatra benzointree Nutrition 0.000 description 1
- 244000223014 Syzygium aromaticum Species 0.000 description 1
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 1
- 244000191422 Terminalia bellirica Species 0.000 description 1
- 235000011517 Terminalia chebula Nutrition 0.000 description 1
- 241000270708 Testudinidae Species 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 235000006533 astragalus Nutrition 0.000 description 1
- 229960002130 benzoin Drugs 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 108010052008 colla corii asini Proteins 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 230000032798 delamination Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000013401 experimental design Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000013773 glyceryl triacetate Nutrition 0.000 description 1
- 239000001087 glyceryl triacetate Substances 0.000 description 1
- 244000237330 gutta percha tree Species 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 229960002622 triacetin Drugs 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 239000010124 zhibai dihuang Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention discloses a flexible pill medicament adhesive and a flexible pill prepared from the adhesive. The adhesive consists of glycerol and medicinal carboxymethyl cellulose salt. The soft pill prepared by the adhesive changes the hardness of the existing concentrated pill, so that the iron pill is changed into an elastic soft pill; improving the disintegration time limit of the original concentrated pill and shortening the disintegration time; the drying process is reduced, the moisture content can be effectively ensured, the efficiency is improved, and the medicine storage is facilitated; removing the coating, and reducing the use of auxiliary materials for coating; and is safe and non-toxic; the adhesive composition is mainly applied to water pills, water-honeyed pills, concentrated pills, small honeyed pills and large honeyed pills, and compared with pills prepared from traditional auxiliary materials, the pills prepared by the invention have the beneficial effect of higher volatile substance content.
Description
Technical Field
The invention relates to a flexible pill medicament adhesive, in particular to a flexible pill prepared by using the adhesive.
Background
The pill refers to a spherical or sphere-like solid preparation prepared from raw material medicaments and appropriate auxiliary materials, and the traditional pills comprise honeyed pills, water-honeyed pills, paste pills, wax pills, concentrated pills and the like. Honeyed pill is prepared from fine powder of decoction pieces by mixing with refined honey as binder; the water-honeyed pill is prepared from decoction pieces by mixing with Mel and water as binder; the watered pill is prepared from decoction pieces fine powder with water (or yellow wine, vinegar, diluted medicinal liquid, sugar solution, and aqueous solution containing refined honey less than 5% according to preparation method) as binder; the paste pill is prepared from decoction pieces fine powder with rice flour, rice paste or flour paste as binder; the concentrated pill is prepared by extracting decoction pieces or part of decoction pieces, concentrating, mixing with appropriate adjuvant or fine powder of other decoction pieces, and making into pill with water, refined honey or refined honey and water as binder. Generally, honeyed pills are prepared from whole powder, the ratio of the added adhesive (refined honey) to the medicinal powder is at least 1:2, the ratio of large honeyed pills is even close to 1:1, the refined honey contains high sucrose and maltose originally, and the honeyed pills are not suitable for being taken by diabetics, and the quality problems of cracking or slow disintegration of the pills and the like can occur in the storage process of water-paste pills or concentrated pills prepared by the traditional adhesive.
Disclosure of Invention
The invention aims to provide a flexible pill medicine adhesive and a flexible pill prepared by using the adhesive. The invention changes the hardness of the prior concentrated pill, so that the iron pill is changed into an elastic flexible pill; the disintegration time limit of the existing concentrated pill is improved, and the disintegration time is shortened; the drying process is reduced, the moisture content can be effectively ensured, the efficiency is improved, and the medicine storage is facilitated; removing the coating, and reducing the use of auxiliary materials for coating; and is safe and non-toxic; the adhesive composition is mainly applied to water pills, water-honeyed pills, concentrated pills, small honeyed pills and large honeyed pills, and compared with pills prepared from traditional auxiliary materials, the soft pills prepared by the invention have higher volatile substance content.
The technical scheme of the invention is as follows:
a flexible pill medicine adhesive is composed of glycerol and medicinal carboxymethyl cellulose salt, wherein the weight ratio of the glycerol to the medicinal carboxymethyl cellulose salt is 100: 1-15.
Specifically, the soft pill medicine adhesive comprises 100 parts by weight of glycerin and 2.5-10 parts by weight of medicinal carboxymethyl cellulose salt.
More specifically, the soft pill medicine adhesive comprises 100 parts by weight of glycerin and 2.5-7.66 parts by weight of medicinal carboxymethyl cellulose salt.
The pharmaceutically acceptable carboxymethyl cellulose salt includes: sodium carboxymethyl cellulose or calcium carboxymethyl cellulose.
The soft pill is added with medicine extract powder or medicinal powder accounting for 50-80% of the total weight of the prepared medicines.
Specifically, the soft pill is added with medicine extract powder or medicinal powder accounting for 55-75% of the total weight of the prepared medicines.
More specifically, the soft pill is added with medicinal extract powder or medicinal powder accounting for 60-70% of the total weight of the prepared medicines.
The flexible pill is prepared by:
(1) putting glycerol into a container, adding medicinal carboxymethyl cellulose salt, stirring, sealing, and heating until the carboxymethyl cellulose salt is completely swelled to obtain adhesive;
(2) preparation of the pill: adding adhesive into the medicinal extract powder or medicinal powder, mixing, and making into pill.
In the step (1), the heating condition is that the mixture is heated for 4 to 10 hours at the temperature of between 60 and 105 ℃, and the mixture is stirred once every 0.5 to 2 hours.
Compared with the prior art, the invention has the following beneficial effects:
the invention is prepared by weighing glycerol and medicinal carboxymethyl cellulose salt, such as sodium carboxymethyl cellulose or calcium carboxymethyl cellulose, according to the proportion of the components, adding the sodium carboxymethyl cellulose or calcium carboxymethyl cellulose into the glycerol at normal temperature, stirring uniformly to uniformly disperse the adhesive in the solvent, and heating for 4-8 hours (preferably 6 hours) under the condition of 50-120 ℃ (preferably 60-105 ℃) to fully swell the adhesive.
The flexible pill medicament adhesive provided by the invention is used for replacing refined honey in large honeyed pills to prepare a novel pill, so that the problem that the pill is not beneficial to being taken by a diabetic patient due to high sugar content is solved, and meanwhile, the quality control of volatile medicaments in the pill can be improved, and the test data of the six-ingredient rehmannia pills and the wolfberry-chrysanthemum rehmannia pills are shown. The flexible pill (children's rejuvenation pill) prepared by the flexible pill medicine adhesive solves the problems of hardness, slow disintegration and difficult absorption of the children's rejuvenation pill, and the prepared novel children's rejuvenation pill is relatively flexible and easy to disintegrate and absorb. The flexible pill prepared by the adhesive can solve the problem of cracking of the gynecological reconstruction pill in the storage process, and improves the product quality.
The adhesive composition is mainly applied to water pills, water-honeyed pills, concentrated pills, small honeyed pills and large honeyed pills, and compared with pills prepared from traditional auxiliary materials, the pills prepared by the invention have higher volatile substance content.
The applicant applies the preparation technology of the soft pills to the gynecological reconstruction pills, the children rejuvenation pills, the six-ingredient rehmannia pills, the medlar-chrysanthemum rehmannia pills, the storax pills and the Zhibai-rehmannia pills, and obtains remarkable effects. In order to research/verify the technical scheme and the beneficial effects of the invention, the inventor conducts a large number of tests, and partial tests are recorded as follows:
the following are the relevant data of the screening test and orthogonal test of the soft pill medicament adhesive and the relevant data of the new preparation method of the children's Huichun pill.
1. Screening of pharmaceutical adjuvant types
The purpose of the test is as follows: screening out proper auxiliary material solvent and adhesive and finding out proper, safe and suitable collocation combination.
The test method comprises the following steps: through the retrieval and analysis of the properties of different pharmaceutic adjuvants, the following solvents are preliminarily screened out, and the solvents and the adhesive are mixed according to a certain proportion.
(1) Glycerol;
(2) tween 80;
(3) propylene glycol;
(4) phenoxyethanol;
(5) polyethylene glycol 400;
screening out several adhesives:
(1) sodium carboxymethylcellulose;
(2) calcium carboxymethylcellulose;
(3) methyl cellulose;
(4) carbomer;
(5) gum arabic powder;
(6) gelatin;
mixing adhesive and solvent uniformly, wherein the proportion of the adhesive is 3%, heating for a certain time at 90 ℃ (the heating aims at shortening the swelling time) to make the adhesive completely swell, measuring the viscosity of the adhesive or adding paste powder to make pills to ensure that the pills can be made smoothly, ensuring that the pills can be completely swelled under a certain condition, achieving the effect of combining the adhesive, observing whether a container has precipitation or delamination, observing whether particles which are not swelled exist on the container wall, and observing whether the two particles have swelling phenomenon or the proportion of the swelling of the adhesive.
Weighing a certain weight of glycerin on a one percent balance, weighing a certain weight of adhesive, adding the adhesive into the glycerin, uniformly stirring to uniformly disperse the adhesive in a solvent, and heating in a stable oven to accelerate the swelling process. Pelleting and checking mixture and viscosity.
Test 1:
test 2:
test 3:
test 4:
test 5:
test 6:
test 7:
test 8:
test 9:
test 10:
according to the fact that the preliminary experiment is a single-factor experiment, it is determined that the factors which have great influence on the pelleting process, the product appearance and the properties during the preparation of the composition agent comprise an adhesive A: percentage of glycerin; the heating temperature of the composition agent B; c combination heating time, therefore 3-factor 3 horizontal quadrature test was designed.
The experimental design was as follows:
and (4) experimental conclusion: the A3B3C2 has the best effect
Test results
The new pill has the advantages that:
1. the hardness of the original concentrated pill is changed, so that the iron pill is changed into an elastic flexible pill. Referring to fig. 153 and 154, the flexible pellets prepared using the present invention were tested to be 0.77kg compared to 3.89kg for the original process pellets (condensation pellets).
2. Improve the disintegration time limit of the original concentrated pill and shorten the disintegration time. The disintegration time of the soft pill prepared by the invention is 43min, compared with the prior art pill (concentrated pill) which is 105min, as shown in figure 155.
3. The drying process is reduced, the moisture content can be effectively ensured, the efficiency is improved, and the medicine storage is facilitated, as shown in figure 156.
Sampling quantity: 33.3300g calculation procedure: 1.8/33.3300 × 100% ═ 5.40%.
4. The soft pill prepared by the invention can remove the coating and reduce the auxiliary materials used for coating.
In conclusion, the invention changes the hardness of the original concentrated pill, so that the iron pill is changed into the elastic flexible pill; improving the disintegration time limit of the original concentrated pill and shortening the disintegration time; the drying process is reduced, the moisture content can be effectively ensured, the efficiency is improved, and the medicine storage is facilitated; removing the coating, and reducing the use of auxiliary materials for coating; and is safe and non-toxic; the adhesive composition is mainly applied to water pills, water-honeyed pills, concentrated pills, small honeyed pills and large honeyed pills, and compared with pills prepared from traditional auxiliary materials, the pills prepared by the invention have the beneficial effect of higher volatile substance content.
Drawings
FIG. 1 is a graph showing the swelling of sodium carboxymethylcellulose in test 1 of the present invention;
FIG. 2 is a graph showing the swelling of sodium carboxymethylcellulose in test 1 of the present invention;
FIG. 3 is a diagram of the pelleting of glycerol + sodium carboxymethylcellulose in test 1 of the present invention;
FIG. 4 is a graph of the pelleting of glycerol + sodium carboxymethylcellulose in test 1 of the present invention;
FIG. 5 is a graph showing the swelling behavior of calcium carboxymethylcellulose in test 1 of the present invention;
FIG. 6 is a graph showing the swelling behavior of calcium carboxymethylcellulose in test 1 of the present invention;
FIG. 7 is a graph of the pelleting of glycerol + carboxymethylcellulose calcium for test 1 of the present invention;
FIG. 8 is a graph of the pelleting of glycerol + carboxymethylcellulose calcium of test 1 of the present invention;
FIG. 9 is a graph showing the swelling of gum arabic in test 1 of the present invention;
FIG. 10 is a graph showing the swelling of gum arabic in test 1 of the present invention;
FIG. 11 is a graph of the pelletization of gum arabic in experiment 1 of the present invention;
FIG. 12 is a graph of the pelletization of gum arabic in experiment 1 of the present invention;
FIG. 13 is a graph showing swelling of carboxymethyl cellulose in test 1 of the present invention;
FIG. 14 is a graph showing swelling of carboxymethyl cellulose in test 1 of the present invention;
FIG. 15 is a graph showing the swelling of carbomer 940 in test 1 of the present invention;
FIG. 16 is a graph showing the swelling of carbomer 940 in trial 1 of the present invention;
FIG. 17 is a graph of the pelleting of glycerol + carbomer 940 in test 1 of the present invention;
FIG. 18 is a graph of the pelleting of glycerol + carbomer 940 in test 1 of the present invention;
FIG. 19 is a graph showing the swelling of carbomer U20 in test 1 of the present invention;
FIG. 20 is a graph showing the swelling of gelatin in test 1 of the present invention;
FIG. 21 is a graph showing the swelling of gelatin in test 1 of the present invention;
FIG. 22 is a graph of the pelleting of gelatin in trial 1 of the present invention;
FIG. 23 is a graph of the pelleting of gelatin in trial 1 of the present invention;
FIG. 24 is a graph showing the swelling of sodium carboxymethylcellulose + glycerol in test 2 of the present invention;
FIG. 25 is a graph of sodium carboxymethylcellulose + glycerol pelleting in test 2 of the present invention;
FIG. 26 is a graph showing the swelling behavior of sodium carboxymethylcellulose + ethylene glycol phenyl ether in test 2 of the present invention;
FIG. 27 is a graph showing the swelling behavior of sodium carboxymethylcellulose + glyceryl triacetate in inventive test 2;
FIG. 28 is a graph showing the swelling of sodium carboxymethylcellulose + ethylene glycol in test 2 of the present invention;
FIG. 29 is a graph showing the swelling of sodium carboxymethylcellulose + ethylene glycol in test 2 of the present invention;
FIG. 30 is a plot of sodium carboxymethylcellulose + ethylene glycol pelleting in test 2 of the present invention;
FIG. 31 is a graph showing the swelling of sodium carboxymethylcellulose +1, 2-propanediol in test 2 of the present invention;
FIG. 32 is a graph showing the swelling of sodium carboxymethylcellulose +1, 2-propanediol in test 2 of the present invention;
FIG. 33 is a graph showing the swelling behavior of sodium carboxymethylcellulose + Tween 80 in test 2 of the present invention;
FIG. 34 is a graph showing the swelling of sodium carboxymethylcellulose + polyethylene glycol 400 in test 2 of the present invention;
FIG. 35 is a graph showing the swelling of sodium carboxymethylcellulose + polyethylene glycol 400 in test 2 of the present invention;
FIG. 36 is a graph showing the swelling behavior of calcium carboxymethylcellulose + glycerol in test 2 of the present invention;
FIG. 37 is a graph of the pelleting of calcium carboxymethylcellulose + glycerol in test 2 of the invention;
FIG. 38 is a graph showing the swelling of gelatin + polyethylene glycol 400 in test 2 of the present invention;
FIG. 39 is a graph showing the swelling of gelatin + polyethylene glycol 400 in test 2 of the present invention;
FIG. 40 is a graph showing the swelling of carbomer 940+ polyethylene glycol 400 in test 2 of the present invention;
FIG. 41 is a graph of the pelleting of carbomer 940+ polyethylene glycol 400 in test 2 of the invention;
FIG. 42 is a graph showing the swelling behavior of calcium carboxymethylcellulose + ethylene glycol in test 2 of the present invention;
FIG. 43 is a graph showing the swelling behavior of calcium carboxymethylcellulose + ethylene glycol in test 2 of the present invention;
FIG. 44 is a graph of the calcium carboxymethylcellulose + ethylene glycol pelleting profile of inventive run 2;
FIG. 45 is a graph showing the swelling behavior of sodium carboxymethylcellulose + water in test 2 of the present invention;
FIG. 46 is a graph showing the swelling behavior of sodium carboxymethylcellulose + water in test 2 of the present invention;
FIG. 47 is a drawing of the pelleting of sodium carboxymethylcellulose + water in test 2 of the invention;
FIG. 48 is a graph showing the swelling behavior of gelatin + water in test 2 of the present invention;
FIG. 49 is a graph showing the swelling of gelatin + water in test 2 of the present invention;
FIG. 50 is a graph of gelatin + water pelleting in experiment 2 of the present invention;
FIG. 51 is a graph of gelatin + water pelleting in experiment 2 of the present invention;
FIG. 52 is a graph of pure glycerol pelleting in test 2 of the present invention;
FIG. 53 is a graph of pure glycerol pelleting in test 2 of the present invention;
FIG. 54 is a graph of the present invention at room temperature addition in experiment 3;
FIG. 55 is a graph of the present invention after swelling at room temperature for 6 hours of addition in test 3;
FIG. 56 is a graph of the present invention at 40 ℃ addition in test 3;
FIG. 57 is a graph of the present invention after swelling at 40 ℃ for 6 hours after addition;
FIG. 58 is a graph of the present invention at 60 ℃ addition in test 3;
FIG. 59 is a graph showing swelling at 60 ℃ for 6 hours in test 3 of the present invention;
FIG. 60 is a graph of the present invention at 90 ℃ addition in test 3;
FIG. 61 is a graph of the present invention after swelling at 90 ℃ for 6 hours after addition;
FIG. 62 is a graph showing swelling at 2 hours in test 4 of the present invention;
FIG. 63 is a graph showing swelling at 4h in test 4 of the present invention;
FIG. 64 is a graph showing swelling at 4 hours in test 4 of the present invention;
FIG. 65 is a graph showing swelling at 6 hours in test 4 of the present invention;
FIG. 66 is a graph showing swelling at 8 hours in test 4 of the present invention;
FIG. 67 is a graph showing swelling at 10 hours in test 4 of the present invention;
FIG. 68 is a graph showing swelling at 16h in test 4 of the present invention;
FIG. 69 is a graph showing swelling at 16h in test 4 of the present invention;
FIG. 70 is a graph showing the heating time at 60 ℃ for 2 hours in test 5 of the present invention;
FIG. 71 is a graph of heating time at 60 ℃ for 6 hours in inventive test 5;
FIG. 72 is a graph of heating time at 75 ℃ for 2 hours in test 5 of the present invention;
FIG. 73 is a graph of heating time at 75 ℃ for 6 hours in test 5 of the present invention;
FIG. 74 is a graph of heating time at 90 ℃ for 2 hours in test 5 of the present invention;
FIG. 75 is a graph of 90 ℃ heating time 6 hours for test 5 of the present invention;
FIG. 76 is a graph of heating time at 105 ℃ for 2 hours in inventive test 5;
FIG. 77 is a graph showing the heating time at 105 ℃ for 6 hours in test 5 of the present invention;
FIG. 78 shows the CMC-Na: test plots for 1.5%, 2.0%, 2.5%, 3.0%, 3.5% glycerol;
FIG. 79 is a CMC-Na: test pattern with 3.0% glycerol;
FIG. 80 is a CMC-Na: test pattern with 4.0% glycerol;
FIG. 81 is a CMC-Na: test pattern with 5.0% glycerol;
FIG. 82 is a CMC-Na: test pattern with 5.0% glycerol;
FIG. 83 is a CMC-Na: test pattern for 7.66% glycerol;
FIG. 84 is a CMC-Na: the glycerol content is 7.66 percent;
FIG. 85 shows the CMC-Na ratio in inventive run 6: test pattern with 10.0% glycerol;
FIG. 86 is a CMC-Na: test pattern with 10.0% glycerol;
FIG. 87 is a CMC-Na: the pill making condition with 10.0% of glycerin is shown in the figure;
FIG. 88 is a photograph of pellets of this invention with an adjuvant ratio of 20.13% in test 7;
FIG. 89 is a photograph of pellets of trial 7 of the present invention having an adjuvant ratio of 20.13%;
FIG. 90 is a photograph of pellets of trial 7 of the present invention having an excipient ratio of 25.24%;
FIG. 91 is a photograph of pellets of trial 7 of the present invention having an excipient ratio of 25.24%;
FIG. 92 is a photograph of pellets of the invention with an adjuvant ratio of 30.35% in test 7;
FIG. 93 is a photograph of pellets of the invention from trial 7 with an adjuvant ratio of 30.35%;
FIG. 94 is a photograph of pellets of this invention with an adjuvant ratio of 35.30% in test 7;
FIG. 95 is a photograph of pellets of the present invention at an adjuvant ratio of 35.30% in test 7;
FIG. 96 is a photograph of pellets of trial 7 of the present invention having an excipient ratio of 40.20%;
FIG. 97 is a photograph of pellets of trial 7 of the present invention having an excipient ratio of 40.20%;
FIG. 98 is a graph of cream powder + glycerin of trial 8 of the present invention;
FIG. 99 is a graph of paste powder + glycerin + CMC-Na in trial 8 of the present invention;
FIG. 100 is a diagram of soft mass of paste powder + glycerin + CMC-Na in test 8 of the present invention;
FIG. 101 is a press pellet of paste powder + glycerin + CMC-Na of trial 8 of the present invention;
FIG. 102 is a graph of paste powder + CMC-Na in test 8 of the present invention;
FIG. 103 is a graph of paste powder + CMC-Na + glycerol in trial 8 of the present invention;
FIG. 104 is a diagram of the soft mass of paste powder + CMC-Na + glycerin in test 8 of the present invention;
FIG. 105 is a press pellet of paste powder + CMC-Na + glycerin of trial 8 of the present invention;
FIG. 106 is a graph of cream powder + glycerin of test 8 of the present invention;
FIG. 107 is a graph of paste powder + glycerin + CMC-Na in trial 8 of the present invention;
FIG. 108 is a graph of the paste powder + glycerin + CMC-Na90 heated at 6 hours in test 8 of the present invention;
FIG. 109 is a graph of paste powder + CMC-Na in test 8 of the present invention;
FIG. 110 is a graph of paste powder + CMC-Na + glycerol in test 8 of the present invention;
FIG. 111 is a graph of the paste powder + CMC-Na + glycerin heated at 90 ℃ for 6 hours in test 8 of the present invention;
FIG. 112 is a graph of CMC-Na + glycerol in test 8 of the present invention;
FIG. 113 is a graph of CMC-Na + glycerol + paste powder in test 8 of the present invention;
FIG. 114 is a diagram of the soft mass of CMC-Na + glycerol + paste powder in test 8 of the present invention;
FIG. 115 is a pellet plot of CMC-Na + glycerol + paste powder from inventive run 8;
FIG. 116 is a graph of CMC-Na + glycerol (heated at 90 ℃ for 6 hours) in test 8 of the present invention;
FIG. 117 is a drawing showing the pelletization of CMC-Na + glycerol (heated at 90 ℃ C. for 6 hours) + paste powder in test 8 of the present invention;
FIG. 118 is a graph of 80 mesh in trial 9 of the present invention;
FIG. 119 is a graph of 80 mesh in trial 9 of the present invention;
FIG. 120 is a graph of 100 of the present invention in experiment 9;
FIG. 121 is a graph of 100 mesh in experiment 9 of the present invention;
FIG. 122 is a graph of 120 mesh in experiment 9 of the present invention;
FIG. 123 is a graph of 120 mesh in experiment 9 of the present invention;
FIG. 124 is a graph of 80, 100 and 120 mesh in experiment 9 of the present invention;
FIG. 125 is a diagram showing the swollen state of the adhesive No. 1 in the test 10 of the present invention;
FIG. 126 is a view showing a swollen state of an adhesive No. 1 in test 10 of the present invention;
FIG. 127 is a view showing a swollen state of an adhesive No. 2 in test 10 of the present invention;
FIG. 128 is a drawing of a series 2 pellet form of trial 10 of the present invention;
FIG. 129 is a diagram showing the swollen state of the adhesive No. 3 in test 10 of the present invention;
FIG. 130 is a view showing a swollen state of an adhesive No. 3 in test 10 of the present invention;
FIG. 131 is a drawing of a series 3 pellet formulation of test 10 of the present invention;
FIG. 132 is a view showing a swollen state of an adhesive No. 4 in test 10 of the present invention;
FIG. 133 is a view showing a swollen state of an adhesive No. 4 in test 10 of the present invention;
FIG. 134 is a drawing of run No. 4 pelletization of test 10 of the present invention;
FIG. 135 is a view showing a swollen state of an adhesive No. 5 in test 10 of the present invention;
FIG. 136 is a view showing a swollen state of an adhesive No. 5 in test 10 of the present invention;
FIG. 137 is a drawing of trial number 5 pellets of the present invention run 10;
FIG. 138 is a view showing a swollen state of an adhesive No. 6 in test 10 of the present invention;
FIG. 139 is a diagram showing a swollen state of an adhesive No. 6 in test 10 of the present invention;
FIG. 140 is a drawing of a series 6 pellet form of test 10 of the present invention;
FIG. 141 is a view showing a swollen state of an adhesive No. 7 in test 10 of the present invention;
FIG. 142 is a view showing a swollen state of an adhesive No. 7 in test 10 of the present invention;
FIG. 143 is a drawing of a series 7 pellet formulation of test 10 of the present invention;
FIG. 144 is a diagram showing a swollen state of an adhesive No. 8 in test 10 of the present invention;
FIG. 145 is a view showing a swollen state of an adhesive No. 8 in test 10 of the present invention;
FIG. 146 is a drawing of trial 10 of the present invention numbered 8 as a pellet;
FIG. 147 is a view showing a swollen state of an adhesive No. 9 in test 10 of the present invention;
FIG. 148 is a view showing a swollen state of an adhesive No. 9 in test 10 of the present invention;
FIG. 149 is a drawing of a series 9 pellet form of trial 10 of the present invention;
FIG. 150 is a view showing a swollen state of an adhesive No. 10 in test 10 of the present invention;
FIG. 151 is a drawing showing the swollen state of the adhesive No. 10 in test 10 of the present invention;
FIG. 152 is a drawing of a series 10 pellet form of trial 10 of the present invention;
fig. 153 is a graph of the hardness of a flexible pellet made using the present invention in test demonstration of the present invention-advantage 1 of the new pellet;
FIG. 154 is a graph of the hardness of the original process pellet (concentrated pellet) as tested for proof of the invention-advantage 1 of the new pellet;
FIG. 155 is a graph of the present invention trial demonstrating disintegration in advantage 2 of the new pellet; (left: flexible pill; right: original concentrated pill)
Fig. 156 is a graph of the moisture content in advantage 3 of the present invention test demonstration-new pellet.
Detailed Description
The invention is further illustrated by the following figures and examples, which are not to be construed as limiting the invention.
Example 1. A gynecological reconstruction pill-soft pill is prepared by the following steps:
(1) paste powder mixture: weighing 65.14g of wine angelica sinensis, 66.14g of vinegar-processed rhizoma cyperi, 43.43g of radix paeoniae alba, 21.71g of prepared rehmannia root, 10.86g of donkey-hide gelatin, 65.14g of poria cocos, 21.71g of codonopsis pilosula, 21.71g of astragalus membranaceus, 32.57g of Chinese yam, 16.28g of bighead atractylodes rhizome, 43.43g of wine-processed glossy privet fruit, 32.57g of vinegar-processed tortoise shell, 21.71g of dogwood, 21.71g of teasel root, 21.71g of salt eucommia ulmoides, 10.86g of cistanche, 16.28g of raspberry, 5.43g of cornu cervi degelatinatum, 43.43g of ligusticum wallichii, 21.71g of salvia miltiorrhiza, 16.28g of achyranthes bidentata, 21.71g of motherwort, 16.28g of corydalis tuber, 5.43g of crisp panax notoginseng, 43.43g of vinegar-processed folium artemisiae argyi, 21.71g of fennel, 21.71g of ligusticum sinensis, 21.71g of cuttlebone 32.57g, 7g of spicebush, 7g of sauted sanguisorba officinalis, 3543 g of radix polygalae, 32.57g of radix gentianae, 3543 g of prepared radix gentianae, 3586 g of prepared radix rehmanniae praeparatae, 3645 g of radix rehmanniae praeparata, 32.57g of honey-fried radix rehmanniae praeparata, 3627.80 g of radix rehmanniae praeparata, 3627 g of honey-fried radix rehmanniae praeparata, 3.32 g of honey-fried radix polygalae, 3526 g of radix rehmanniae preparata, 3627 g of honey-fried radix rehmanniae praeparata, 3.32 g of honey-fried radix polygalae, 3g of honey-fried radix polygalae, 3.35 g of honey-fried radix rehmanniae praeparata, 3g of honey-fried radix et radix polygalae, 3.71 g of honey-fried radix et radix polygalae, 3g of honey-fried radix polygalae, 3.32 g of honey-fried radix et radix salviae, 3g of honey-fried radix et radix polygalae, 3g of radix et radix salviae, 3g of radix salviae officinalis, 3.32 g of radix et radix salviae officinalis, 3g of honey-fried radix salviae miltiorrhizae, 3.35 g of radix et radix salviae officinalis, 3g of radix salviae miltiorrhizae, 3g of radix et radix salviae officinalis, 3.27 g of radix et radix salviae miltiorrhizae, 3g of honey-fried radix et rhizoma, 3g of honey-fried radix et radix salviae miltiorrhizae, 3.27 g of honey-fried radix et radix salviae miltiorrhizae, 3g of radix salviae sinensis, 3.35 g of radix et radix salviae miltiorrhizae, 3g of radix et radix salviae sinensis, 3.7 g of honey-fried radix et radix salviae miltiorrhizae, 3g of honey-fried radix et rhizoma, 3g of honey-fried radix et rhizoma, 3.27 g of honey-fried radix salviae miltiorrhizae, 3.32 g of honey-fried radix salviae miltiorrhizae, decocting Cistanchis herba, Achyranthis radix and cortex Lycii in water twice, each for two hours, mixing decoctions, filtering, and concentrating the filtrate to obtain concentrated solution; melting colla Corii Asini in appropriate amount of water, mixing with the above concentrated solution, concentrating to obtain fluid extract with relative density of 1.10 at 80 deg.C, pulverizing the rest thirty-three materials, sieving with 100 mesh sieve to obtain fine powder, and mixing the fluid extract and fine powder to obtain paste powder mixture;
(2) adhesive: putting 100g of glycerol into a container, adding 4g of sodium carboxymethylcellulose, uniformly stirring, sealing, heating the container at 90 ℃ for 6 hours, and stirring once every 1.5 hours to prepare an adhesive for later use;
(3) gynecological reconstruction pill-soft pill: and (3) adding 35% of the adhesive in the step (2) into the paste powder mixture in the step (1), uniformly mixing, and making into pills.
Example 2. A preparation method of a gynecological reconstruction pill comprises the following steps:
(1) a paste powder mixture was prepared as described in example 1;
(2) adhesive: adding 100g of glycerol into a container, adding 15g of carboxymethylcellulose calcium, uniformly stirring, sealing, heating the container at 105 ℃ for 4-5 hours until the carboxymethylcellulose calcium is completely swelled, and stirring once every 0.5 hour to prepare an adhesive for later use;
(3) gynecological reconstruction pill-soft pill: adding binder 50% of the total amount of the prepared medicinal materials into the paste powder mixture, mixing, and making into pill.
Example 3. A method for preparing a pill of six ingredients with rehmannia, namely a soft pill, comprises the following steps:
(1) powder: according to the prescription of the pill of six ingredients with rehmannia, 160g of prepared rehmannia root, 80g of wine-processed cornus, 60g of tree peony bark, 80g of Chinese yam, 60g of tuckahoe and 60g of alisma orientale, crushing, sieving and uniformly mixing to obtain medicinal powder;
(2) adhesive: according to the weight ratio, 100g of glycerol is put into a container, then 5g of calcium carboxymethylcellulose is added, the mixture is uniformly stirred and heated for 5 to 6 hours at the temperature of 95 ℃ until the calcium carboxymethylcellulose is completely swelled, and the adhesive is obtained;
(3) pill of six ingredients with rehmannia: adding binder 40% of the total amount of the prepared medicinal materials into the medicinal powder mixture, mixing, and making into pill.
Example 4. A preparation method of Qiju Dihuang Wan-Soft pill comprises the following steps:
(1) powder: according to the weight ratio, 40 parts of medlar, 40 parts of chrysanthemum, 160 parts of prepared rehmannia root, 80 parts of wine dogwood fruit, 60 parts of tree peony bark, 80 parts of Chinese yam, 60 parts of tuckahoe and 60 parts of alisma orientale are taken; pulverizing the Chinese medicinal materials, sieving, and mixing to obtain medicinal powder;
(2) preparation of the adhesive: adding 100g of glycerol into a container, adding 4g of carboxymethylcellulose calcium, stirring uniformly, sealing, heating at 70-80 ℃ for 9-10 hours until the carboxymethylcellulose calcium is completely swelled, and stirring once every 2 hours to prepare an adhesive for later use;
(3) preparation of the pill: adding binder in an amount of 28% of the total amount of the prepared medicinal materials, mixing, and making into pill.
Example 5. A preparation method of a flexible rejuvenation pill for children comprises the following steps:
(1) paste powder mixture: taking 25 parts of coptis chinensis, 50 parts of buffalo horn concentrated powder, 25 parts of antelope horn, 25 parts of calcined chinese cabbage, 25 parts of fermented soybean, 50 parts of folium isatidis, 50 parts of schizonepeta, 50 parts of notopterygium root, 50 parts of kudzu root, 50 parts of rehmannia, 50 parts of caulis clematidis armandii, 50 parts of red paeony root, 50 parts of scutellaria baicalensis, 75 parts of radix peucedani, 75 parts of radix scrophulariae, 75 parts of platycodon grandiflorum, 37.5 parts of radix bupleuri, 37.5 parts of cacumen tamaricis, 20 parts of rhizoma cimicifugae and 75 parts of fried burdock; pulverizing cornu Saigae Tataricae into fine powder, and mixing with pulvis Cornus Bubali Concentratus to obtain mixture A; pulverizing 2/3 of the rest materials into fine powder, sieving with 80 mesh sieve, mixing the above fine powder with the above QINGGAO to obtain paste powder mixture;
(2) preparation of the adhesive: adding 100g of glycerol into a container, adding 4g of sodium carboxymethylcellulose, stirring uniformly, sealing, heating at 105 ℃ for 4 hours until the sodium carboxymethylcellulose is completely swelled, and stirring once every 2 hours to obtain an adhesive for later use;
(3) preparation of the pill: adding binder 29% of the total amount of the prepared medicinal materials into the medicinal powder, mixing, and making into pill.
Example 6. A preparation method of a flexible rejuvenation pill for children comprises the following steps:
(1) paste powder mixture: prepared according to the method of example 5;
(2) preparation of the adhesive: adding 100g of glycerol into a container, adding 10g of carboxymethylcellulose calcium, stirring uniformly, sealing, heating at 95 ℃ for 6 hours until the carboxymethylcellulose calcium is completely swelled, and stirring once every 1 hour to obtain an adhesive for later use;
(3) preparation of the pill: adding adhesive in an amount of 30% of the total amount of the prepared medicinal materials into the medicinal powder, mixing, and making into pill.
Example 7. A preparation method of Qijudihuang pills comprises the following steps:
(1) powder: according to the weight ratio, 40 parts of medlar, 40 parts of chrysanthemum, 160 parts of prepared rehmannia root, 80 parts of wine dogwood fruit, 60 parts of tree peony bark, 80 parts of Chinese yam, 60 parts of tuckahoe and 60 parts of alisma orientale are taken; pulverizing the Chinese medicinal materials, sieving, and mixing to obtain medicinal powder;
(2) preparation of the adhesive: adding 100g of glycerol into a container, adding 4g of carboxymethylcellulose calcium, stirring uniformly, sealing, heating at 70-80 ℃ for 9-10 hours until the carboxymethylcellulose calcium is completely swelled, and stirring once every 2 hours to prepare an adhesive for later use;
(3) preparation of the pill: adding binder in an amount of 28% of the total amount of the prepared medicinal materials, mixing, and making into pill.
Example 8. A preparation method of Qijudihuang pills comprises the following steps:
(1) powder: preparing a powder as described in example 7;
(2) preparation of the adhesive: adding 100g of glycerol into a container, adding 7g of carboxymethylcellulose calcium, stirring uniformly, sealing, heating at 90-95 ℃ for 5-6 hours until the carboxymethylcellulose calcium is completely swelled, and stirring once every 1.5 hours to prepare an adhesive for later use;
(3) preparation of the pill: adding binder accounting for 25% of the total amount of the prepared medicine into the medicinal powder, mixing uniformly, and making into pills.
Example 9. A preparation method of storax pills comprises the following steps:
(1) mixing the medicines: weighing 50g of storax, 100g of benzoin, 50g of borneol, 200g of buffalo horn concentrated powder, 75g of artificial musk, 100g of sandalwood, 100g of agilawood, 100g of clove, 100g of rhizoma cyperi, 100g of elecampane, 100g of prepared frankincense, 100g of long pepper, 100g of bighead atractylodes rhizome, 100g of myrobalan meat and 100g of cinnabar according to the weight components, and refining cinnabar into fine powder by water except the storax, the artificial musk, the borneol and the buffalo horn concentrated powder; pulverizing the rest materials into fine powder; respectively grinding Moschus, Borneolum Syntheticum, and pulvis Cornus Bubali Concentratus into fine powder, mixing with above powder, grinding, sieving, and mixing to obtain mixed medicinal powder; stewing storax to obtain mixed medicinal powder;
(2) preparation of the adhesive: adding 100g of glycerol into a container, adding 4.15g of sodium carboxymethylcellulose, stirring uniformly, sealing, heating at 90 ℃ for 7 hours until the sodium carboxymethylcellulose is completely swelled, and stirring once every 1 hour to prepare an adhesive for later use;
(3) preparation of the pill: adding adhesive in an amount which is 38 percent of the mixed medicinal powder into the medicinal powder, uniformly mixing, and making into pills.
Example 10. A preparation method of Zhibai Dihuang Wan is prepared according to the following steps:
(1) powder: weighing 40g of rhizoma anemarrhenae, 40g of cortex phellodendri, 160g of prepared rehmannia root, 80g of dogwood (prepared), 60g of moutan bark, 80g of Chinese yam, 60g of poria cocos and 60g of rhizoma alismatis according to weight components, crushing, sieving and uniformly mixing to obtain medicinal powder;
(2) preparation of the adhesive: adding 100g of glycerol into a container, adding 4.16g of sodium carboxymethylcellulose, stirring uniformly, sealing, heating at 105 ℃ for 4 hours until the sodium carboxymethylcellulose is completely swelled, and stirring once every 0.5 hour to obtain an adhesive for later use;
(3) preparation of the pill: adding adhesive in the amount of 32% of the total amount of the prepared medicinal materials, mixing, and making into pill.
Claims (10)
1. The flexible pill medicine adhesive is characterized in that: the adhesive consists of glycerol and medicinal carboxymethyl cellulose salt, wherein the weight ratio of the glycerol to the medicinal carboxymethyl cellulose salt is 100: 1-15.
2. The pliable pill drug adhesive of claim 1, wherein: the weight ratio of glycerin to medicinal carboxymethyl cellulose salt is 100: 2.5-10.
3. The pliable pill drug adhesive of claim 1, wherein: according to the weight ratio, glycerin and medicinal carboxymethyl cellulose salt are 100: 2.5-7.66.
4. The pliable pill drug binder of any one of claims 1-3 wherein: the pharmaceutically acceptable carboxymethyl cellulose salt includes: sodium carboxymethyl cellulose or calcium carboxymethyl cellulose.
5. Flexible pellets made with the binder of any of claims 1 to 3, characterized in that: the soft pill is added with medicine extract powder or medicinal powder accounting for 50-80% of the total weight of the prepared medicines.
6. A flexible pellet formulation with the binder of claim 5 wherein: the soft pill is added with medicine extract powder or medicinal powder accounting for 55-75% of the total weight of the prepared medicines.
7. A flexible pellet formulation with the adhesive of claim 6 wherein: the soft pill is added with medicinal extract powder or medicinal powder accounting for 60-70% of the total weight of the prepared medicines.
8. A flexible pellet formulation formed with the binder of any one of claims 5 to 7 wherein: the flexible pill is prepared by:
(1) putting glycerol into a container, adding medicinal carboxymethyl cellulose salt, stirring, sealing, and heating until the carboxymethyl cellulose salt is completely swelled to obtain adhesive;
(2) preparation of the pill: adding adhesive into the medicinal extract powder or medicinal powder, mixing, and making into pill.
9. A flexible pellet formulation with the adhesive of claim 8 wherein: in the step (1), the heating condition is heating at 60-105 ℃ for 4-10 hours.
10. A flexible pellet formulation with the adhesive of claim 8 wherein: in the step (1), the stirring is carried out once every 0.5-2 hours during the heating.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110485920.7A CN113546049B (en) | 2021-04-30 | 2021-04-30 | Flexible pill medicine adhesive and flexible pill prepared by using same |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110485920.7A CN113546049B (en) | 2021-04-30 | 2021-04-30 | Flexible pill medicine adhesive and flexible pill prepared by using same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN113546049A true CN113546049A (en) | 2021-10-26 |
| CN113546049B CN113546049B (en) | 2023-03-17 |
Family
ID=78130158
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202110485920.7A Active CN113546049B (en) | 2021-04-30 | 2021-04-30 | Flexible pill medicine adhesive and flexible pill prepared by using same |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN113546049B (en) |
Citations (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN85101711A (en) * | 1984-05-22 | 1987-01-31 | 拜尔股份公司 | The preparation new cephalosporins and process for their |
| CN1141590A (en) * | 1994-02-22 | 1997-01-29 | 株式会社绿十字 | Medicaments for the prophylaxis and treatment of thromboxane A2-mediated diseases |
| CN1329492A (en) * | 1998-12-07 | 2002-01-02 | 日产化学工业株式会社 | Remedial agent for erectile dysfunction |
| CN1579494A (en) * | 2004-01-13 | 2005-02-16 | 贵州益佰制药股份有限公司 | Micropill of traditional Chinese medicine and its preparation method |
| CN101084986A (en) * | 2006-06-08 | 2007-12-12 | 天津天士力制药股份有限公司 | Traditional Chinese medicinal composition containing notoginseng and kudzuvine root and its preparation |
| CN101099762A (en) * | 2006-07-07 | 2008-01-09 | 上海雷允上科技发展有限公司 | Blood pressue lowering sustained-release preparation with chrysanthemum flower and pearl |
| JP2009155434A (en) * | 2007-12-26 | 2009-07-16 | Lion Corp | Water-containing adhesive, patch and method for producing water-containing adhesive |
| CN102579408A (en) * | 2012-03-19 | 2012-07-18 | 河南中帅医药科技发展有限公司 | Doxycycline hydrochloride dual-release preparation and preparation method thereof |
| CN103655727A (en) * | 2013-12-09 | 2014-03-26 | 贵州信邦制药股份有限公司 | Condensed pill prepared from ligustrum lucidum and radix astragali and capable of reinforcing healthy qi, and preparation method thereof |
| CN104739773A (en) * | 2013-12-26 | 2015-07-01 | 鲁南贝特制药有限公司 | Dexibuprofen slow release pellet and preparation method thereof |
| CN111281853A (en) * | 2018-12-07 | 2020-06-16 | 桂林三金药业股份有限公司 | Preparation method of traditional Chinese medicine concentrated pill |
| US20210015715A1 (en) * | 2019-07-18 | 2021-01-21 | Cintamani Poland Majewscy i Koc Spólka jawna | Adhesive for dental prostheses |
-
2021
- 2021-04-30 CN CN202110485920.7A patent/CN113546049B/en active Active
Patent Citations (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN85101711A (en) * | 1984-05-22 | 1987-01-31 | 拜尔股份公司 | The preparation new cephalosporins and process for their |
| CN1141590A (en) * | 1994-02-22 | 1997-01-29 | 株式会社绿十字 | Medicaments for the prophylaxis and treatment of thromboxane A2-mediated diseases |
| CN1329492A (en) * | 1998-12-07 | 2002-01-02 | 日产化学工业株式会社 | Remedial agent for erectile dysfunction |
| CN1579494A (en) * | 2004-01-13 | 2005-02-16 | 贵州益佰制药股份有限公司 | Micropill of traditional Chinese medicine and its preparation method |
| CN101084986A (en) * | 2006-06-08 | 2007-12-12 | 天津天士力制药股份有限公司 | Traditional Chinese medicinal composition containing notoginseng and kudzuvine root and its preparation |
| CN101099762A (en) * | 2006-07-07 | 2008-01-09 | 上海雷允上科技发展有限公司 | Blood pressue lowering sustained-release preparation with chrysanthemum flower and pearl |
| JP2009155434A (en) * | 2007-12-26 | 2009-07-16 | Lion Corp | Water-containing adhesive, patch and method for producing water-containing adhesive |
| CN102579408A (en) * | 2012-03-19 | 2012-07-18 | 河南中帅医药科技发展有限公司 | Doxycycline hydrochloride dual-release preparation and preparation method thereof |
| CN103655727A (en) * | 2013-12-09 | 2014-03-26 | 贵州信邦制药股份有限公司 | Condensed pill prepared from ligustrum lucidum and radix astragali and capable of reinforcing healthy qi, and preparation method thereof |
| CN104739773A (en) * | 2013-12-26 | 2015-07-01 | 鲁南贝特制药有限公司 | Dexibuprofen slow release pellet and preparation method thereof |
| CN111281853A (en) * | 2018-12-07 | 2020-06-16 | 桂林三金药业股份有限公司 | Preparation method of traditional Chinese medicine concentrated pill |
| US20210015715A1 (en) * | 2019-07-18 | 2021-01-21 | Cintamani Poland Majewscy i Koc Spólka jawna | Adhesive for dental prostheses |
Non-Patent Citations (2)
| Title |
|---|
| 王亮明: "《药剂学指南》", 30 June 1986, 四川科学技术出版社 * |
| 陈思义: "《药剂学》", 28 February 1965, 人民卫生出版社 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN113546049B (en) | 2023-03-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN107744510A (en) | A kind of preparation method of micro-pill type granule | |
| CN102416139B (en) | Chinese medicine composition for treating breast diseases | |
| CN106324174A (en) | Quality standard for traditional Chinese medicine formula granules | |
| CN112999171B (en) | Formula granule containing fiber Mongolian medicine powder and preparation method thereof | |
| CN101579500A (en) | Gynaecologic restorative pharmaceutic preparation and preparation technology and quality control method thereof | |
| CN106018576A (en) | Establishment method for UPLC fingerprint spectrum of gynecological reconstruction pill | |
| CN111467451A (en) | Composition and preparation for treating novel coronavirus pneumonia and application of composition and preparation | |
| CN103610659B (en) | A kind of Allicin medicinal composition and preparation method thereof | |
| CN101239166B (en) | Blood-regulating and face-nourishing capsule and preparation thereof | |
| CN103285207B (en) | Miao medicine for treating dysfunctional uterine bleeding and preparation method thereof | |
| CN101049429A (en) | Tablet for regulating menstruation and removing speckles of department of gynecology, and preparation method | |
| CN103550164B (en) | A kind of GUIPI WAN (micropill) of replenishing QI to invigorate the spleen | |
| CN107335029B (en) | Preparation method of intestine-clearing and middle-warming granules | |
| CN113546049B (en) | Flexible pill medicine adhesive and flexible pill prepared by using same | |
| CN102048991B (en) | Sugar-reducing comfort pill and preparation method thereof | |
| CN103961582B (en) | Treat the Chinese medicine composition and its preparation and preparation method of ephritis | |
| CN112220859B (en) | Preparation process of compound traditional Chinese medicine preparation | |
| CN100415258C (en) | A traditional Chinese medicine composition for treating leukopenia and its preparation and quality control method | |
| CN101199669A (en) | Chinese medicine compound agent for treating female sperm quality lowclass | |
| CN114522217A (en) | Preparation process of medicine for treating diabetes | |
| CN113237990A (en) | Method for identifying liquorice component in traditional Chinese medicine composition | |
| CN101474332A (en) | Danxiang capsule and preparation method thereof | |
| CN100485388C (en) | Oral preparation of 'Guipixin', method for preparing same and quality control method thereof | |
| CN100341548C (en) | Chinese medicine formulation for treating disney disease and toxuria, and its preparing method | |
| CN105012528B (en) | The tool Chinese medicine composition of slow releasing function, the glad ball of heart and brain and its method and preparation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20230823 Address after: No.8, Zone A, Zhazuo Pharmaceutical Park, Xiuwen County, Guiyang City, Guizhou Province, 550200 Patentee after: Guizhou Dechangxiang Pharmaceutical Co.,Ltd. Address before: No.118 Chuangwei Road, Baiyun District, Guiyang City, Guizhou Province Patentee before: HANFANG PHARMA CO.,LTD. Patentee before: Guiyang Dechangxiang Pharmaceutical Co.,Ltd. |